Keywords: strong, pkc, profile, bay, 79-4980, german, drugmaker

Strong PKC profile for BAY 79-4980

Article | 29 May 2006

Print This

German drugmaker Bayer AG has presented data from two early-stage clinical trials at the World Federation of Hemophilia, held in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in